Whittemore Tingley - 17 Feb 2026 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role
Chief Medical Officer
Signature
/s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
Issuer symbol
TNYA
Transactions as of
17 Feb 2026
Net transactions value
-$3,319
Form type
4
Filing time
17 Feb 2026, 19:13:30 UTC
Previous filing
05 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tingley Whittemore Chief Medical Officer C/O TENAYA THERAPEUTICS, INC., 171 OYSTER POINT BLVD., 5TH FLOOR, SOUTH SAN FRANCISCO /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact 17 Feb 2026 0001868494

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNYA Common Stock Sale $1,056 -1,642 -0.73% $0.6432 222,136 17 Feb 2026 Direct F1, F2, F3
transaction TNYA Common Stock Sale $1,056 -1,642 -0.74% $0.6432 220,494 17 Feb 2026 Direct F2, F4, F5
transaction TNYA Common Stock Sale $1,206 -1,876 -0.85% $0.6431 218,618 17 Feb 2026 Direct F2, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.
F2 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 Includes 130,213 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 5,102 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on December 10, 2025.
F4 Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024.
F5 Includes 125,838 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F6 Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025.
F7 Includes 120,838 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.